These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 18090504

  • 1. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D, Wittchen HU, Kavoussi R, Brock J, Baldinetti F, Pande AC.
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [Abstract] [Full Text] [Related]

  • 2. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.
    Montgomery S, Emir B, Haswell H, Prieto R.
    Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960
    [Abstract] [Full Text] [Related]

  • 3. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC.
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.
    Feltner DE, Liu-Dumaw M, Schweizer E, Bielski R.
    Int Clin Psychopharmacol; 2011 Jul; 26(4):213-20. PubMed ID: 21368587
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.
    Feltner DE, Crockatt JG, Dubovsky SJ, Cohn CK, Shrivastava RK, Targum SD, Liu-Dumaw M, Carter CM, Pande AC.
    J Clin Psychopharmacol; 2003 Jun; 23(3):240-9. PubMed ID: 12826986
    [Abstract] [Full Text] [Related]

  • 6. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ, Mandel FS, Schweizer E.
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study.
    Greist JH, Liu-Dumaw M, Schweizer E, Feltner D.
    Int Clin Psychopharmacol; 2011 Sep; 26(5):243-51. PubMed ID: 21734588
    [Abstract] [Full Text] [Related]

  • 8. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.
    Kasper S, Brasser M, Schweizer E, Lyndon G, Prieto R.
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):125-32. PubMed ID: 24290532
    [Abstract] [Full Text] [Related]

  • 9. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B, Wedekind D, Leon T.
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [Abstract] [Full Text] [Related]

  • 10. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM, Powe KW, Cates ME.
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [Abstract] [Full Text] [Related]

  • 11. Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?
    Baldwin DS, Schweizer E, Xu Y, Lyndon G.
    Eur Neuropsychopharmacol; 2012 Feb; 22(2):137-42. PubMed ID: 21839620
    [Abstract] [Full Text] [Related]

  • 12. Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorder.
    Baldwin DS, Loft H, Florea I.
    Int Clin Psychopharmacol; 2012 Jul; 27(4):197-207. PubMed ID: 22475889
    [Abstract] [Full Text] [Related]

  • 13. Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
    Pande AC, Crockatt JG, Feltner DE, Janney CA, Smith WT, Weisler R, Londborg PD, Bielski RJ, Zimbroff DL, Davidson JR, Liu-Dumaw M.
    Am J Psychiatry; 2003 Mar; 160(3):533-40. PubMed ID: 12611835
    [Abstract] [Full Text] [Related]

  • 14. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 15. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder.
    Kasper S, Iglesias-García C, Schweizer E, Wilson J, DuBrava S, Prieto R, Pitman VW, Knapp L.
    Int J Neuropsychopharmacol; 2014 May; 17(5):685-95. PubMed ID: 24351233
    [Abstract] [Full Text] [Related]

  • 16. Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model.
    Nutt D, Mandel F, Baldinetti F.
    J Psychopharmacol; 2009 Nov; 23(8):867-73. PubMed ID: 18635690
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE, Lee DI, Lee SC, Song SO, Yoon DM, Yoon MH, Kim HK, Lee YW, Kim C, Lee PB.
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.
    Montgomery SA, Tobias K, Zornberg GL, Kasper S, Pande AC.
    J Clin Psychiatry; 2006 May; 67(5):771-82. PubMed ID: 16841627
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study.
    Merideth C, Cutler AJ, She F, Eriksson H.
    Int Clin Psychopharmacol; 2012 Jan; 27(1):40-54. PubMed ID: 22045039
    [Abstract] [Full Text] [Related]

  • 20. Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States.
    Rothschild AJ, Mahableshwarkar AR, Jacobsen P, Yan M, Sheehan DV.
    Eur Neuropsychopharmacol; 2012 Dec; 22(12):858-66. PubMed ID: 22901736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.